Eperezolid (Standard)
Eperezolid (Standard) is an analytical standard for Eperezolid. This product is intended for research and analytical applications. Eperezolid (PNU-100592) is an oxazolidinone antibiotic with good in vitro inhibitory properties.
Product Specifications
CAS Number
165800-04-4
Product Name Alternative
PNU-100592 (Standard)
UNSPSC
12352005
Target
Antibiotic; Bacterial; Reference Standards
Related Pathways
Anti-infection; Others
Field of Research
Infection
Smiles
O=C(O[C@H]1CNC(C)=O)N(C1)C2=CC(F)=C(C=C2)N3CCN(CC3)C(CO)=O
Molecular Formula
C18H23FN4O5
Molecular Weight
394.40
References & Citations
[1]Rybak MJ, et al. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium. Antimicrob Agents Chemother. 1998 Mar;42 (3) :721-4.|[2]Lin AH, et al. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin. Antimicrob Agents Chemother. 1997 Oct;41 (10) :2127-31.|[3]Zhou CC, et al. 1H nuclear magnetic resonance study of oxazolidinone binding to bacterial ribosomes. Antimicrob Agents Chemother. 2002 Mar;46 (3) :625-9.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV728617 1.0 µg DNA
HOXB-AS3 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 
orb1638893-01 50 µg
Mitochondrial peptide methionine sulfoxide reductase
Sign In for Pricing
View Details orb1638893-02 100 µg
Mitochondrial peptide methionine sulfoxide reductase
Sign In for Pricing
View Details orb1638893-03 1 mg
Mitochondrial peptide methionine sulfoxide reductase
Sign In for Pricing
View Details 
A11611-2-Dylight488 100 µg
Anti-POLR3D Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details